Ventyx Biosciences (VTYX) Earnings Date, Estimates & Call Transcripts $2.29 +0.14 (+6.51%) (As of 09:47 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 8) -$0.45 Beat By $0.12 Consensus EPS (Aug. 8) -$0.57 Conference Call TranscriptConference Call AudioEarnings Press Release Get Ventyx Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for VTYX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVTYX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VTYX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Monetary GoldBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Ventyx Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.71)($0.71)($0.71)Q2 20241($0.73)($0.73)($0.73)Q3 20241($0.75)($0.75)($0.75)Q4 20241($0.77)($0.77)($0.77)FY 20244($2.96)($2.96)($2.96)VTYX Earnings Date and InformationVentyx Biosciences last posted its quarterly earnings results on August 8th, 2024. The reported ($0.45) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.57) by $0.12. Ventyx Biosciences has generated ($3.24) earnings per share over the last year (($3.24) diluted earnings per share). Earnings for Ventyx Biosciences are expected to decrease in the coming year, from ($2.14) to ($2.18) per share. Ventyx Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.Read More Ventyx Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/8/2024-($0.57)($0.45)+$0.12($0.45)-- 5/9/2024Q1 2024($0.67)($0.62)+$0.05($0.62)-- 2/27/2024Q4 2023($0.87)($0.79)+$0.08($0.79)-- 11/9/2023Q3 2023($0.89)($0.92)($0.03)($0.92)-- 8/10/2023Q2 2023($0.71)($0.91)($0.20)($0.91)-- 5/11/2023Q1 2023($0.64)($0.68)($0.04)($0.68)-- Get the Latest News and Ratings for VTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 3/23/2023Q4 2022($0.59)($0.62)($0.03)($0.62)-- 11/3/2022Q3 2022($0.45)($0.59)($0.14)($0.59)-- 8/15/2022Q2 2022($0.47)($0.39)+$0.08($0.39)-- 5/12/2022Q1 2022($0.37)($0.45)($0.08)($0.45)-- 11/17/2021Q3 2021($0.34)($3.17)($2.83)($3.17)-- Ventyx Biosciences Earnings - Frequently Asked Questions When is Ventyx Biosciences's earnings date? Ventyx Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on VTYX's earnings history. Did Ventyx Biosciences beat their earnings estimates last quarter? In the previous quarter, Ventyx Biosciences (NASDAQ:VTYX) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.57) by $0.12. Learn more on analysts' earnings estimate vs. VTYX's actual earnings. How can I listen to Ventyx Biosciences's earnings conference call? The conference call for Ventyx Biosciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Ventyx Biosciences's conference call transcript? The conference call transcript for Ventyx Biosciences's latest earnings report can be read online. Read Transcript How much profit does Ventyx Biosciences generate each year? Ventyx Biosciences (NASDAQ:VTYX) has a recorded net income of -$192.96 million. VTYX has generated -$3.24 earnings per share over the last four quarters. What is Ventyx Biosciences's EPS forecast for next year? Ventyx Biosciences's earnings are expected to decrease from ($2.14) per share to ($2.18) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Exscientia Earnings Y-mAbs Therapeutics Earnings Applied Therapeutics Earnings Terns Pharmaceuticals Earnings REGENXBIO Earnings iTeos Therapeutics Earnings Annexon Earnings SIGA Technologies Earnings Silence Therapeutics Earnings Alector Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:VTYX) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored"Doomsday indicator” flashing for the first time since the Great Depression...It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTYX Stock Alerts